Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Orchiectomy
  • Prostatic Neoplasms

abstract

  • An updated prognostic model for OS in patients with mCRPC receiving first-line chemotherapy was developed and validated on an external set. This model can be used to predict OS, as well as to better select patients to participate in trials on the basis of their prognosis.

publication date

  • March 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3927736

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.52.3696

PubMed ID

  • 24449231

Additional Document Info

start page

  • 671

end page

  • 7

volume

  • 32

number

  • 7